Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_eaede00dfb0f76826d6f4c73888c939e http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dc08e5ae34c60388d8772fad157bd6ec http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_77f26b9e6a953844d925cf7370e3a2c0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f833f5e52fc1e88c1926f598d7de0879 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b7973e007004cae0135a18b3cc34e798 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3a313ab4c9a64d4cd1674c4893ce944b http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f020ae493f8ab1cfdc878df41ed54232 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-209 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-24 |
filingDate |
2005-04-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7063a0f9d5eb28fca13156e0bcb8ae4b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_858dfb97e2c549e5da2e2d3b295bf9b8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4fee500e9c5bd42575cab11f00ae2ed2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_579ff4fe6c05c877f8c7830335547cd7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3683a5d6c94537441105df93bd01a191 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_116f432bf4e568d064e36153a541adba http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_31429c5e2a599dae542da28630ea2ba7 |
publicationDate |
2010-06-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2010151022-A9 |
titleOfInvention |
Controlled-release compositions |
abstract |
A solid dosage formulation having a core with a pharmacological agent dispersed in a first controlled-release matrix from which release of the agent is relatively slow; and a coat formed over the core and having the agent dispersed in a second controlled-release matrix from which release of the agent is relatively fast. The first matrix can be a cross-linked high amylose starch and the second matrix can be a mixture of polyvinyl acetate and polyvinylpyrrolidone. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020072773-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11273218-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/IL-282006-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11324733-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11311522-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2780318-C1 |
priorityDate |
2002-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |